Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photodynamic therapy for skin rejuvenation: comparison of standard vs daylight PDT
2017-003626-32Phase 2Terminated
- Sponsor
- Medical University of Vienna
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of 5-aminolevulinic acid in photoaging and actinic elastosis (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Change in Photoaging Score. Started Nov 2017; status: terminated.
02
Drugs
5-aminolevulinic acid
03
Conditions
photoagingactinic elastosis
Beyond the preview
Go deeper on 2017-003626-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003626-32.